Litcius/Paper detail

LBA74 Pembrolizumab plus chemotherapy vs chemotherapy as neoadjuvant and adjuvant therapy in locally-advanced gastric and gastroesophageal junction cancer: The phase III KEYNOTE-585 study

Kohei Shitara, Sun Young Rha, Lucjan Wyrwicz, Takashi Oshima, Nina Karaseva, M. A. Osipov, Hisateru Yasui, Hiroshi Yabusaki, S. G. Afanasyev, Park Yk, S-E. Al-Batran, Takaki Yoshikawa, P.E. Yanez Weber, Maria Di Bartolomeo, Sara Lonardi, Xuemin Fang, C-S. Shih, Pooja Bhagia, Y-J. Bang

2023Annals of Oncology34 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePembrolizumabChemotherapyGastroesophageal JunctionCancerOncologyInternal medicineAdjuvantAdjuvant chemotherapyPhases of clinical researchAdenocarcinomaImmunotherapyBreast cancerGastric Cancer Management and OutcomesCancer Immunotherapy and BiomarkersGastrointestinal Tumor Research and Treatment
LBA74 Pembrolizumab plus chemotherapy vs chemotherapy as neoadjuvant and adjuvant therapy in locally-advanced gastric and gastroesophageal junction cancer: The phase III KEYNOTE-585 study | Litcius